As the first artificial intelligence (AI) payment blockchain, Kite offers investors exposure to AI and blockchain technology. If AI agents take off as expected, they could lead to soaring demand for ...

The S&P 500 has returned 54% since the current bull market started in October 2022. Midterm election years frequently ...

Home Depot has boosted its dividend payout every year since 2010 and yields 2.6%. Meanwhile, Sherwin-Williams just raised its dividend for the 47th consecutive year, but it only yields 1% because the ...

Lucid's business model is compelling. Both Tesla and Rivian are far ahead in realizing the potential of their technology. But there's a problem: This savvy approach to business strategy doesn't ...

Corning is a leading supplier of fiber-optic cables for data centers, which transmit information far more efficiently than traditional copper cables. The company's CEO believes the market for data ...

While 2026's Social Security COLA may be beating inflation now, beneficiaries are likely to lose buying power for one big reason -- their expenses tend to rise faster than the CPI-W. And that's ...

Unusual Machines is increasing its manufacturing capacity. Management pegs the company's near-term addressable market at $250 million. Unusual Machines raised capital via multiple stock offerings in ...

Keithen Drury is a contributing Motley Fool technology analyst covering AI, semiconductors, cybersecurity, and SaaS stocks. In addition to The Motley Fool, Keithen is a mechanical engineer and has ...

Stanley Druckenmiller has been a big investor in AI, previously holding shares of leaders including Nvidia and Palantir. The billionaire has a long history of delivering gains to investors in his fund ...

Amazon, Google, and others made waves earlier this year when they projected incredible boosts to their AI spending for 2026. Amazon alone projected $200 billion in capital expenditure ( capex) for ...

Browse investing articles and stock analysis by Tim Beyers. Get expert financial insights and investment advice from The Motley Fool.

Keith Speights is a contributing Motley Fool healthcare analyst covering publicly traded companies across pharmaceuticals, biotechnology, medical devices, technology, and marijuana. Prior to The ...